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ABSTRACT 
The &blocker DL-1 -(2-nitro-3-methylphenoxy)-3-tert-butylaminopropan-2-01 
(ZAMI 1305), hepatocarcinogenic to the female rat, and the non-oncogenic 8- 
blockers ~~-1-(2-nitro-5-methylphenoxy)-3-terf-butylam~nopropan-2-01 (ZAMI 
1327), Di-propranolol, and m-atenolol were studied for their capacity to inter- 
fere with hepatic DNA and RNA synthesis. These moieties inhibit DNA and RNA 
synthesis, in a dose-dependent fashion, when added in vitro to nuclei isolated 
from the liver of male or female rats. The inhibition i s  due to a decrease of the 
initial rate of synthesis and of the total amount of labeled precursor incorporated 
into the growing chains. When administered in vivo both the oncogenic ZAMI 
1305 and its non-oncogenic isomer ZAMI 1327 inhibit hepatic DNA and RNA 
synthesis in female rats, as evaluated by the determination of nucleic acids 
synthesis in liver nuclei isolated from female rats 5 and 15 min after the injection 
of the drug. No influence on hepatic DNA and RNA synthesis i s  observed when 
the molecules are administered to male rats. The in vivo administration of DL- 
propranolol causes an increase of hepatic DNA and RNA synthesis in male rats, 
while it i s  uneffective i n  female rats. 
I N T R O D U C T I O N  
Tumor-promoting (5) and oncogenic (8, 9, 
20) activities have been reported for some p- 
adrenoreceptor blocking agents. As for other 
chemicals, the oncogenic activity of &block- 
ers may depend on an interaction of the mol- 
ecule with the template primer DNA (1, 11, 
12, 17, 29) and/or with the DNA and RNA 
polymerases (7, 10, 11, 13). However, this 
capacity is common to other non-oncogenic 
molecules (18, 26, 27, 33). 
Results obtained in our laboratory have 
demonstrated that the hepatocarcinogenic p- 
blocker ~~-1-(2-nitr0-3-methylphenoxy)-3- 
tert-butylaminopropan-2-01 (ZAMI 1305) (25) 
and its non-oncogenic isomer ~~-1-(2-nitro-5- 
methylphenoxy)-3-tert-bu tylaminopropan-2- 
* Requests for reprints should be addressed to Dr. Ragnotti 
at: Laboratorio di Patologia Cenerale. Facolti di hledicina e 
Chirurgia, via Valsabbina 19. 25124 Brescia. Italy. 
01 (ZAMI 1327) (25), neither of which was 
ever used in therapy, both inhibit the in vitro 
activities of purified yeast DNA polymerase I 
(24) and DNA polymerases at and p isolated 
from rat liver (22). Although confirming the 
capacity of a carcinogen to interfere with 
nucleic acids synthesis, our results do not 
clarify whether a cause-effect relationship 
exists between the capacity of a molecule to 
affect nucleic acids synthesis and its onco- 
genicity or not; possibly, this is because pu- 
rified DNA polymerases represent a too sim- 
plified biologic system with respect to intact 
rat liver. 
The effect of ZAMI 1305 and ZAMI 1327 
on DNA and RNA synthesis in more complex 
biologic systems was then evaluated. In the 
in vitro experiments DNA and RNA synthesis 
was measured in nuclei isolated from livers 
of untreated rats of both sexes and added /3- 
blockers, while in the in vivo experiments 
18 
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these parameters were evaluated in liver nu- 
clei isolated from male and female rats 
treated with the @-blocker. 
This experimental schema showed the pos- 
sible differences in the action of the hepato- 
carcinogen ZAMI 1305 with respect to the 
non-oncogenic ZAMI 1327 on hepatic nucleic 
acids synthesis and also, since ZAMI 1305 is 
oncogenic to the liver of female but not of 
male rat (25), the different effects on the two 
sexes. 
Since two other non-oncogenic @-blockers, 
DL-propranolol and DL-atenolol, inhibit the in 
vitro activity of yeast DNA polymerase I (24) 
and of rat liver DNA polymerases (Y and @ 
(22), the capacity of these molecules to affect 
DNA and RNA synthesis in isolated liver 
nuclei was also tested. 
MATERIALS ND METtiODS 
Chemicals 
Nucleotides and deoxynucleotides were 
purchased from C. F. Boehringer und Soehne 
GmbH (Mannheim, West Germany). Other 
chemicals were of analytical reagent grade 
and were obtained from E. Merck A.G. 
(Darmstadt, West Germany) or from British 
Drug Houses (Poole, Dorset, United King- 
dom). [3H]dTTP and [14C]UTP were pur- 
chased from Radiochemical Centre (Amer- 
sham, Bucks, United Kingdom). ZAMI 1305, 
ZAMI 1327, DL-propranolol, and DL-atenolol 
were gifts from Zambeletti S.p.A. (20021 Bar- 
anzate, Milan, Italy). 
Animals . 
Male and female outbred Wistar rats (Nos- 
san, Correzzana, Italy) weighing 130-1 60 g 
were used. Animals were maintained on a 
standard diet of laboratory chow (Piccioni, 
Brescia, Italy) and water ad libitum through- 
out the experimental period. Constant tem- 
perature (22-23°C) and alternating periods of 
12-hr dark and 12-hr light were also main- 
tained. 
In Vitro Experiments 
Isolation of Liver Nuclei. Nuclei were iso- 
lated from the liver of untreated male and 
female rats as previously described (31). 
Briefly, liver was passed through a tissue 
press made to the design of Porterfield (21) 
and homogenized in 2.0 volumes of a sucrose 
solution (0.32 M sucrose, 3 mM MgC1, adjusted 
to pH 7.4 with NaHC03). Aliquots (10 ml) of 
homogenate were layered on a 10-ml sucrose 
cushion (0.5 M, pH 7.4) and centrifuged at 700 
x g for 10 min. Pellets were resuspended in 
13 ml of 2.4 M sucrose, 1 mhi MgCl,, 0.2 mM 
spermidine and centrifuged at 100,000 x g 
for 60 min. The resulting nuclear fraction 
was resuspended (2 x 10' nuclei/ml) in 50 
mM Tris-HC1 (pH 8.3), 5 mM MgCl,, 5 mM 
dithiothreitol, 0.1 mM EDTA (sodium salt), 
and 25% glycerol for the determination of 
DNA and RNA synthesis. 
DNA Synthesis. This was determined as 
previously described (6). Briefly, nuclear sus- 
pension was diluted to 2 x l o7  nuclei/ml with 
0.32 M sucrose, 50 mhi 4-(2-hydroxyethyl)-l- 
piperazineethanesulfonic acid (Hepes) (pH 
7 4 ,  and incubated at 4°C for 15 min with 
different concentrations (see Fig. 1) of @- 
blockers dissolved in Hepes buffer (pH 7.5). 
Control samples were incubated with equi- 
molar concentrations of NaCl. Aliquots of the 
nuclear suspensions (I x 10' nuclei) were 
added to the assay medium containing (final 
concentrations): 10 mhi ATP; 0.5 mhi each of 
dATP, dCTP, and dGTP; 1.2 PM [3H]dTTP (958 
mCi/mmol); 10 mM MgCl,; 50 mM Hepes 
buffer (pH 7.5). After a 30-min incubation at 
37"C, DNA synthesis was stopped by the ad- 
dition of cold 10% trichloroacetic acid, and 
the acid-precipitable material was collected 
on GF/C discs (2.5-cm diameter, Whatman 
Ltd., England). Discs, after washing and 
drying, were added with 10 ml of a scintilla- 
tion solution (5.5 g Permablend I/700 ml 
toluo1/300 ml ethylene glycol monomethyl 
ether) and counted for radioactivity in a 
Beckman LS 7500 @-counter with an error of 
5% or better. In some experiments nuclei 
concentration or time of incubation was var- 
ied as specified in  Figures 2A and 3A. 
RNA Synthesis. This was determined as 
previously described (31). Briefly, nuclear 
suspension was diluted to 2 x 10' nuclei/ml 
with 50 mM Tris-HC1 (pH 8.3), 5 mM MgC12, 5 
mM dithiothreitol, 0.1 mhi EDTA, and incu- 
bated at 4°C for 5 min with different concen- 
trations of the @-blocker tested, dissolved in 
Tris-HC1 (pH 8.3). Control samples were in- 
cubated with equimolar concentrations of 
NaCl. Aliquots of the nuclear suspension (1 
x 10' nuclei) were added to the assay me- 
dium containing (final concentrations): 50 
mM Tris-HC1 (pH 8.3); 0.5 mM each of ATP, 
CTP, and GTP; 0.037 mM ['4C]UTP (2 Ci/ 
mmol); 1 mhi MnCl,; 2.5 mhi dithiothreitol; 
0.05 mhi EDTA; 0.2 mg/ml bovine serum al- 
bumin. After a 10-min incubation at 37°C the 
reaction was stopped by the addition of cold 
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10% trichloroacetic acid. The radioactivity 
incorporated into the acid-precipitable ma- 
terial was determined as described for DNA 
synthesis. In some experiments, nuclei con- 
centration or the time of incubation was var- 
ied as specified in Figures 2B and 3B. 
In Vivo Experiments 
Because atenolol showed such a small ef- 
fect in the in vitro experiments (Figs. 1- 
3), it was omitted from the in vivo experi- 
ments. A total of 90 male and 90 female 
Wistar rats was used. Control animals were 
given an i.p. injection of saline; experimental 
animals were treated i.p. with ZAMI 1305 
(100 mg/kg body weight) or ZAMI 1327 (100 
mg/kg body weight or DL-propranolol(75 mg/ 
kg body weight) dissolved in saline. This 
route of exposure was chosen to obtain a 
rapid and reproducible absorption of the 
drugs into the liver. At 5 or 15 min after the 
injection, the animals were killed by cervical 
dislocation. Each experimental group con- 
sisted, for each sex, of 10 control animals, 10 
animals killed 5 min, and 10 animals killed 
15 min after the injection of the @-blocker. In 
each experiment, livers from 2 or 3 animals 
. were quickly removed and pooled together, 
nuclei were isolated, and DNA and RNA syn- 
thesis were determined as described for the 
in vitro experiments, with the difference that 
2 x loG and 2 x 10' nuclei/incubation were 
utilized for the determination of DNA and 
RNA synthesis, respectively. In each experi- 
ment nuclei isolated from livers of 2-3 male 
and 2-3 female rats treated with saline were 
used as controls; 'the amount of DNA and 
RNA synthesis in treated animals is ex- 
pressed as percentage of the controls. 
RESULTS 
In preliminary experiments performed to 
determine the contribution of the different 
DNA and RNA polymerases to DNA and RNA 
synthesis in isolated liver nuclei, nuclei iso- 
Iated from both male and female rat liver 
were incubated with 100 pg/ml heparin or 4 
mM p-hydroxymercuribenzoate (inhibitors of 
DNA polymerase a activity (6)) or 5 pg/ml a- 
amanitin (inhibitor of RNA polymerase I1 ac- 
tivity (15)). Heparin or p-hydroxymercuri- 
benzoate reduce the amount of DNA synthe- 
sis to 2-3% of the control, indicating that 
under our experimental conditions DNA syn- 
thesis is due exclusively to the activity of 
DNA polymerase a. a-Amanitin reduces the 
amount of RNA synthesis to 70% of the con- 
trol, indicating that 70% of RNA synthesis is 
due to RNA polymerase I activity and 30% to 
RNA polymerase I1 activity. Under our ex- 
perimental conditions, RNA polymerase 111 
activity is considered to be negligible (15). 
In Vitro Experiments. ZAMI 1305, ZAMI 
1327, DL-propranolol, and DL-atenolol, when 
added to liver nuclei isolated from both male 
and female rat liver, inhibit DNA and RNA 
synthesis in a dose-dependent fashion with 
DL-propranolol being the most effective (Fig. 
1, A and B). All of the 8-blockers tested, 
except DL-atenolol, affect DNA synthesis 
more than RNA synthesis. For a given con- 
centration of the 8-blocker tested, an increase 
of nuclei concentration in the assay mixture 
causes a decrease of the degree of inhibition 
of DNA and RNA synthesis (Fig. 2, A and B). 
The analysis of the kinetics of the hcorpo- 
ration of [3H]dTTP and [14C]UTP (Fig. 3, A 
and B) shows that the @-blockers decrease the 
initial rate of synthesis and the total amount 
of the labeled precursor incorporated into the 
growing chains. 
To evaluate the possibility of a different 
susceptibility of RNA polymerases I and I1 to 
@-blocker inhibition, nuclei were incubated 
with the @-blocker and RNA synthesis was 
measured in the absence and in the presence 
IA 
. 
13 28 4 2  0 
P-blocker ( m M )  
FIG. 1-/n vitro inhibition of D N A  (A) and RNA 
(B) synthesis by &blockers in nuclei isolated from 
the liver of female rat. For the details of nuclei 
isolation, incubation with &blockers, and evalua- 
tion of D N A  and RNA synthesis see "Materials and 
Methods." Each point is the mean of 3-4 experi- 
ments in triplicate. D N A  and RNA synthesis in 
control nuclei (taken as 100%) was equal to 1 pmol 
['HIdTTP incorporated/hr/106 nuclei and 6 pmol 
["CIUTP incorporated/hr/lO' nuclei, respectively. 
Similar results are obtained when nuclei isolated 
from the liver of male rats are used. A, m-atenolol; 
0, ZAMI 1327; 0, ZAMI 1305; A, m-propranolol. 
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1 1. I .- 
0 2 1 6 8 0 2 4 6 8  
(nuclci/incubation).106 
FIG. 2-Effect of different concentrations of 
nuclei on the in vilro inhibition of DNA (A) and 
RNA (B) synthesis by @-blockers. For the details of 
nuclei isolation, incubation with &blockers, and 
evaluation of DNA and RNA synthesis see "Mate- 
rials and Methods." &Blockers were at the  final 
concentration of 10 mM (A) or 14 mM (B). Each 
point is the mean of 3 experiments in triplicate. A, 
DL-atenolol; 0, ZAMl 1327; 0, ZAMl 1305; A, DL- 
propranolol. 
I /- 
. 
0 30 60 120 0 10 2 0  30 
l ime o f  incubation ( m i n )  
FIG. 3-Effect of &blockers on the kinetics of 
incorporation in vifro of ['HJdTTP in DNA (A) and 
["CIUTP in RNA (B) in nuclei isolated from the 
liver of female rat. For the details of nuclei isola- 
tion, incubation with &blockers, and evaluation of 
DNA and RNA synthesis see "Materials and Meth- 
ods." Each &blocker was 28 mM. Each point is the 
mean of 2 experiments in triplicate. 0, control; A, 
oi-atenolol; 0, ZAMl 1327; 0, ZAMl 1305; A, DL- 
propranolol. 
of 5 pg/ml a-amanitin. The results (Fig. 4) 
demonstrate that the four @-blockers inhibit 
RNA polymerases I and I1 to a similar extent. 
In Vivo Experiments. Since the in vitro ex- 
periments were unable to show any differ- 
ence on DNA and RNA synthesis between 
the effect of the sex-dependent oncogenic 
ZAMI 1305 and that of the other nononco- 
genic @-blockers, the capacity of ZAMI 1305, 
its non-oncogenic isomer ZAMI 1327, and the 
non-oncogenic DL-propranolol to affect he- 
patic DNA and RNA synthesis was measured 
in nuclei isolated from the liver of animals 
treated in vivo with the p-blocker. DNA and 
RNA synthesis in isolated nuclei, depending 
on the in vitro elongation of the DNA and 
RNA chains initiated in vivo (6, 21, 31) rep- 
resents in fact a parameter well related to the 
amount of the nucleic acids synthesis occur- 
ring in vivo at the time of death of the animal. 
At 5 or 15 min after the administration of 
ZAMI 1305 or ZAMI 1327, no modification, 
in respect to the controls, of the amount of 
the hepatic DNA and RNA synthesis is de- 
tectable in male rats (Fig. 5); but ZAMI 1305 
or ZAMI 1327 administration to female rats 
does affect both DNA and RNA synthesis 
(Fig. 5). In fact both molecules inhibit DNA 
and RNA synthesis in respect to the controls 
at 5 min; the inhibition is overcome at i5 
min. DL-Propranolol administration causes an 
increase of DNA and RNA synthesis both at 
5 and 15 min in male rats, but it is uneffective 
in female rats (Fig. 5). 
The different sex response to @-blockers 
100 
n c.
c 
.- 
a 
u 50 w 
ta 
u 
.- 
c - 
h 
A B C 
FIG. 4-Effect of &blockers on RNA polymer- 
ase I and II activities in nuclei isolated from the 
liver of female rat. For the details of nuclei isola- 
tion, incubation with &blockers, and evaluation of 
RNA synthesis see "Materials and Methods." Each 
&blocker was 42 mM. Each value is the  mean of 2 
experiments in triplicate. A, RNA polymerase I and 
I1 activity (incubation without a-amanitin); B, RNA 
polymerase I activity (incubation with 5 pg/ml a- 
amanitin); C, RNA polymerase ll activity (calcu- 
lated by subtracting from each value shown in A 
the corresponding value shown in B). 0, control; 
0, atenolol; 0, ZAMl 1327; 8, ZAMl 1305; B, 
propranolol. 
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FIG. 5-DNA and RNA synthesis in liver nuclei 
isolated from male and female rats treated with 
ZAMll305 or ZAMl1327(100 mg/kg body weight) 
or DL-propranolol (75 mg/kg body weight). The 
drugs were injected i.p. and the animals were killed 
5 or 15 min thereafter. For nuclei isolation and 
evaluation of DNA and RNA synthesis see "Mate- 
rials and Methods." Each point is the mean f S.E.M. 
of 3-5 experiments in triplicate. Shaded area rep- 
resents the variability of the control. 0, ZAMl 1305; 
A, ZAMl 1327; H, DL-propranolol. 
= I  40 
administration is particularly evident when, 
for all of the individual experiments, the var- 
iation of DNA synthesis is plotted versus that 
of RNA synthesis (Fig. 6). The linear discrim- 
inant function analysis (2) performed on the 
above parameters independently of the time 
of treatment and of the drug administered 
does in fact demonstrate that male and fe- 
male rats constitute two separate popula- 
tions, which are different in their sensitivity 
to &blockers. This discrimination is limited 
to the effect exerted by these molecules on 
DNA synthesis, which is not evident for RNA 
synthesis. From Fig. 6 it also appears that 
within the same sex a rather high variability 
of response to 8-blocker administration is 
present. Since in control animals, for a given 
experiment, the value of the S.E.M. for the 
parameters tested is low, the variability does 
not appear to depend on experimental-errors, 
but rather to reflect a physiological situation. 
,Discussio~ 
The oncogenic 8-blocker ZAMI 1305 and 
the non-oncogenic 8-blockers ZAMI 1327, DL- 
propranolol, and DL-atenolol inhibit DNA and 
RNA synthesis in a dose-dependent fashion 
when added in vitro to nuclei isolated from 
the liver of both male and female rats. 
The mechanism of inhibition of nucleic 
acids synthesis by 8-blockers could reside, as 
Experimental 
group 
males 
females 
Assigned group*,b 
males f e m a l e s  
15 4 
9 16 
40 70 1bO 130 160 
DNA synthesis (%of t h e  control) 
FIG. 6-Hepatic DNA and RNA synthesis after 8-blockers administration: linear discriminant function 
analysis of the data obtained in male versus female rats. The analysis was performed by comparing the 
two sexes independently of the  time of treatment and of the &blocker administered. The discriminant 
function is: z = x - 0.0034 y, where x and y are the percentage of modification, in respect to the controls,. 
of DNA and RNA synthesis, respectively. The  data shown are those utilized in Fig. 5. Each point represents 
one experiment. Shaded area represents the variability (2  S.E.M.) of the controls. 0, A, 0, males; 0, A, D, 
females; 0 and 0, ZAMl 1305; A and A, ZAMl 1327; 0 and ., DL-propranolol. 'By the discriminant function 
analysis the points are assigned to the group of males for z > 96.86 and to the group of females for z c 
96.86. *Significance (p  < 0.01) of the difference of assignment of male versus female rats was assessed by 
X2 test. The  significance of the test indicates the efficacy of the linear discriminant function analysis to 
separate t h e  two sexes. 
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for others chemicals (1, 7, 10-13, 17, 29), in 
an interaction of these molecules with the 
template primer DNA and/or with the DNA 
and RNA polymerases. An interaction with 
DNA is indirectly supported by the consid- 
eration that all of the @-blockers tested except 
DL-atenolol cause DNA fragmentation when 
added in vitro to isolated liver nuclei (23). On 
the other hand, this does not seem to be the 
main mechanism involved since: (a) DL-aten- 
olol, which inhibits to some extent DNA and 
RNA synthesis, does not affect DNA integrity 
(23); (b) the four@-blockiirs tested in this work 
inhibit the activity of purified yeast DNA 
polymerase I (24) and of isolated mammalian 
DNA polymerases (Y and @ (22) by interacting 
with the enzyme and not with the activated 
DNA. 
It seems possible to hypothesize that the 
interaction of the 8-blockers with DNA and 
RNA polymerases represents the main mech- 
anism of inhibition of DNA and RNA synthe- 
sis in isolated liver nuclei. Even though the 
nature of the interaction is at present un- 
known, it is worth noting that for all biosyn- 
thetic processes studied in our laboratory 
(DNA and RNA synthesis in isolated liver 
nuclei, in vitro activity of yeast DNA poly- 
merase I (24), and in vitro activities of hepatic 
DNA polymerases (Y and B (22)), the inhibitory 
capacity of @-blockers increases in this order: 
DL-atenolo1 C ZAMI 1327 5 ZAMI 1305 < DL- 
propranolol. Since these molecules differ es- 
sentially for the structure of their aromatic 
moiety, the observation suggests that this por- 
tion of the &blocker molecule plays an im- 
portant role in the inhibitory activity of these 
drugs and that the inhibition is caused by a 
mechanism common to all the biologic sys- 
tems studied. 
The in vitro experiments performed on iso- 
lated liver nuclei, as well those on yeast DNA 
polymerase I (24) and on isolated rat liver 
DNA polymerases a and (22), failed to dem- 
onstrate any difference between the effects 
exerted by oncogenic and non-oncogenic @- 
blockers. Therefore, we have investigated if 
these molecules, according to their different 
oncogenic potential, exerted a different influ- 
ence on hepatic nucleic acids synthesis in 
vivo. Accordingly, we have compared the 
effect of ZAMI 1305 administration in female 
rats (the sex susceptible to the oncogenic 
activity of this molecule) to that observed in 
male rats and the effect of this oncogen to 
that of the non-oncogenic @-blockers ZAMI 
1327 and DL-propranolol in rats of both sexes. 
In female rats inhibition of both DNA and 
RNA synthesis is observed for all of the p- 
blockers tested in most of the experiments, 
even though in some experiments, especially 
after DL-propranolol administration, activa- 
tion of DNA and/or RNA synthesis is also 
observed (see Fig. 6). In male rats DL-propran- 
olol induces an increase of nucleic acids syn- 
thesis; the rate of synthesis is unaffected by 
the administration of both ZAMIs. Thus, the 
@-blockers tested, independently of their dif- 
ferent oncogenicity, affect hepatic nucleic 
acids synthesis in a different manner in fe- 
male and in male rats. 
On this basis the following points are worth 
discussion: (a) the different effect of &block- 
ers administration on DNA and RNA synthe- 
sis in female versus male rat liver; (b) the 
different influence exerted by the two ZAMIs 
versus DL-propranolol in the two sexes. Dif- 
ferent hypotheses can be made to explain 
the sex-dependent effect of &blockers on 
DNA and RNA synthesis. A different bioa- 
vailability of these molecules to the nucleus 
of the hepatocyte in the two sexes could 
depend on a different permeability of the cell 
membrane and/or on a different transport 
through the cytoplasm to the nucleus. It must 
be pointed out however that the transport of 
DL-propranolol through the cell membrane of 
the hepatocyte is a passive, not saturable 
process (19), and therefore remarkable differ- 
ences in the two sexes in this respect seem 
to be unlikely. Different hepatic metabolism 
of @-blockers in the two sexes is well known. 
In fact the activity of the hepatic microsomal 
mixed function oxidase system is lower in 
female than in male rat (14). This could cause 
a reduced rate of inactivation of P-blockers 
by female rat liver, with a consequent higher 
inhibitory effect by these molecules in this 
sex. Preliminary experiments (not shown) in- 
dicate that three metabolites of ZAMI 1305 
(2-nitro-3-methylphenoxypropan-1,2-diol; 
2-nitro-3-me thylphenoxyet hylaminopropan- 
2-01; 2-amino-3-methylphenoxy-tert-butyl- 
aminopropan-2-01) present in the urine of 
male and female treated animals (25) do not 
affect in vitro nucleic acids synthesis. Quan- 
ti  ta tively different pharmacologic activity of 
&blockers in the two sexes. 8-Blockade, with 
a consequent decrease of intracellular levels 
of CAMP (4, 28), could enhance cellular mul- 
tiplication (30), hence increasing nucleic 
acids synthesis. Estrogens are demonstrated 
to affect the number of @-receptors and their 
affinity for sympathicomimetic amines (3,16, 
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32). This could cause, for a given @-blocker, 
a different modulation of 8-receptors in the 
two sexes, with a consequent different influ- 
ence on the intracellular levels of CAMP. 
At present no experimental data are avail- 
able to prove any of these hypotheses; further 
studies are therefore necessary to clarify the 
sex-dependent response of nucleic acid syn- 
thesis in rat liver to @-blocker administration. 
The molecules tested influence hepatic 
nucleic acids synthesis independently of 
their different oncogenic capacity. Similar 
results are in fact obtained after administra- 
tion of the oncogenic ZAMI 1305 and of the 
non-oncogenic ZAMI 1327, while the non- 
oncogenic DL-propranolol affects DNA and 
RNA synthesis in a different manner in re- 
spect to the two ZAMIs. The different effect 
exerted by the &blockers tested could de- 
pend on the same mechanisms previously 
hypothesized to explain the different re- 
sponse observed in the two sexes. For both 
ZAMIs, molecules strictly related by chemi- 
cal structure, one or more of these mecha- 
nisms could be relevant in determining the 
in vivo alterations of nucleic acids synthesis 
in respect to DL-propranolol molecule with a 
. quite different chemical structure; in this 
latter case the pharmacologic 8-blockade 
could exert, with the CAMP-mediated mech- 
anism previously proposed, a predominant 
role. 
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